Neuro-Oncology Reviews
Volume
25 Number 9
15 May 2023
Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 9, 15 May
*
Fernandes RT, Teixeira GR, Mamere
EC, Bandeira GA, Mamere AE.
The
2021 World Health Organization classification of gliomas: an
imaging approach.
Radiol
Bras. 2023 May-Jun;56(3):157-161∟.
doi: 10.1590/0100-3984.2022.0089-en∟.
PMID: 37564083∟.
Pictorial
essay.
ˍ
McCornack C, Woodiwiss T, Hardi A, Yano H, Kim AH.
The
function of histone methylation and acetylation regulators in GBM
pathophysiology.
Front
Oncol. 2023 May 2;13:1144184∟.
doi: 10.3389/fonc.2023.1144184∟.
PMID: 37205197∟.
Review. ˍ
Meng Y, Sun J, Zhang G, Yu T, Piao H.
Bacteria
associated with glioma: a next wave in cancer treatment.
Front
Cell Infect Microbiol. 2023 May 2;13:1164654∟.
doi: 10.3389/fcimb.2023.1164654∟.
PMID: 37201117∟.
Review. ˍ
Dillman RO, Nistor GI, Keirstead HS.
Autologous
dendritic cells loaded with antigens from self-renewing autologous
tumor cells as patient-specific therapeutic cancer vaccines.
Hum
Vaccin Immunother. 2023 May 3:2198467∟.
doi: 10.1080/21645515.2023.2198467∟.
PMID: 37133853∟.
Review. ˍ
Khatami SH, Karami N, Taheri-Anganeh M, Taghvimi S, Tondro G,
Khorsand M, Soltani Fard E, Sedighimehr N, Kazemi M, Rahimi Jaberi
K, Moradi M, Nafisi Fard P, Darvishi MH, Movahedpour A.
Exosomes:
Promising Delivery Tools for Overcoming Blood-Brain Barrier and
Glioblastoma Therapy.
Mol
Neurobiol. 2023 May 3:1–20∟.
doi: 10.1007/s12035-023-03365-0∟.
PMID: 37138197∟.
Review. ˍ
Murdaugh RL, Anastas JN.
Applying
single cell multi-omic analyses to understand treatment resistance
in pediatric high grade glioma.
Front
Pharmacol. 2023 May 3;14:1002296∟.
doi: 10.3389/fphar.2023.1002296∟.
PMID: 37205910∟.
Review. ˍ
Zhang Q, Wang J, Zhang J, Liu F.
Potential
functions and therapeutic implications of glioma-resident
mesenchymal stem cells.
Cell
Biol Toxicol. 2023 May 3∟.
doi: 10.1007/s10565-023-09808-7∟.
PMID: 37138122∟.
Review˰ ˍ
de Biase D, Franceschi E, Marucci G.
Editorial:
Advances in brain tumors diagnosis and treatment.
Front
Med (Lausanne). 2023 May 4;10:1152547∟.
doi: 10.3389/fmed.2023.1152547∟.
PMID: 37215713∟.
Editorial. ˍ
Padmakumar S, Amiji MM.
Long-Acting
Therapeutic Delivery Systems for the Treatment of Gliomas.
Adv
Drug Deliv Rev. 2023 May 4:114853∟.
doi: 10.1016/j.addr.2023.114853∟.
PMID: 37149040∟.
Review˰ ˍ
Shi T, Zhu J, Zhang X, Mao X.
The Role
of Hypoxia and Cancer Stem Cells in Development of
Glioblastoma.
Cancers
(Basel). 2023 May 4;15(9):2613∟.
doi: 10.3390/cancers15092613∟.
PMID: 37174078∟.
Review. ˍ
Henssen D, Leijten L, Meijer FJA, van der Kolk A, Arens AIJ, Ter
Laan M, Smeenk RJ, Gijtenbeek A, van de Giessen EM, Tolboom N,
Oprea-Lager DE, Smits M, Nagarajah J.
Head-To-Head
Comparison of PET and Perfusion Weighted MRI Techniques to
Distinguish Treatment Related Abnormalities from Tumor Progression
in Glioma.
Cancers
(Basel). 2023 May 5;15(9):2631∟.
doi: 10.3390/cancers15092631∟.
PMID: 37174097∟.
Review. ˍ
Sun W, Song C, Tang C, Pan C, Xue P, Fan J, Qiao Y.
Performance
of deep learning algorithms to distinguish high-grade glioma from
low-grade glioma: A systematic review and meta-analysis.
iScience.
2023 May 5;26(6):106815∟.
doi: 10.1016/j.isci.2023.106815∟.
PMID: 37250800∟.
Review, Meta-analysis. ˍ
Wei D, Zhang N, Qu S, Wang H, Li J.
Advances
in nanotechnology for the treatment of GBM.
Front
Neurosci. 2023 May 5;17:1180943∟.
doi: 10.3389/fnins.2023.1180943∟.
PMID: 37214394∟.
Review. ˍ
Iturrioz-Rodríguez N, Sampron N, Matheu A.
Current
advances in temozolomide encapsulation for the enhancement of
glioblastoma treatment.
Theranostics.
2023 May 8;13(9):2734-2756∟.
doi: 10.7150/thno.82005∟.
PMID: 37284445∟.
Review. ˍ
Lassaletta Á, Morales JS, Valenzuela PL, Esteso B, Kahalley
LS, Mabbott DJ, Unnikrishnan S, Panizo E, Calvo F.
Neurocognitive
outcomes in pediatric brain tumors after treatment with proton
versus photon radiation: a systematic review and
meta-analysis.
World J
Pediatr. 2023 May 8∟.
doi: 10.1007/s12519-023-00726-6∟.
PMID: 37154861∟.
Review, Meta-analysis. ˍ
Liu
C, Kuang S, Wu L, Cheng Q, Gong X, Wu J, Zhang L.
Radiotherapy
and radio-sensitization in H3K27M-mutated
diffuse midline gliomas.
CNS
Neurosci Ther. 2023 May 8∟.
doi: 10.1111/cns.14225∟.
PMID: 37157237∟.
Review. ˍ
Sim HW, Lorrey S, Khasraw M.
Advances
in Treatment of Isocitrate Dehydrogenase (IDH)-Wildtype
Glioblastomas.
Curr
Neurol Neurosci Rep. 2023 May 8∟.
doi: 10.1007/s11910-023-01268-0∟.
PMID: 37154886∟.
Review˰ ˍ
Elshaer SS, Abulsoud AI, Fathi D, Abdelmaksoud NM, Zaki MB,
El-Mahdy HA, Ismail A, Elsakka EGE, Abd-Elmawla MA, Abulsoud LA,
Doghish AS.
miRNAs role in glioblastoma
pathogenesis and targeted therapy: Signaling pathways
interplay.
Pathol Res
Pract. 2023 May 9;246:154511∟.
doi: 10.1016/j.prp.2023.154511∟.
PMID: 37178618∟.
Review˰ ˍ
Meldolesi J.
Role of Senescent
Astrocytes in Health and Disease.
Int
J Mol Sci. 2023 May 9;24(10):8498∟.
doi: 10.3390/ijms24108498∟.
PMID: 37239843∟.
Review. ˍ
Segura-Collar B, Hiller-Vallina S, de Dios O, Caamaño-Moreno
M, Mondejar-Ruescas L, Sepulveda-Sanchez JM, Gargini R.
Advanced
immunotherapies for glioblastoma: tumor neoantigen vaccines in
combination with immunomodulators.
Acta
Neuropathol Commun. 2023 May 10;11(1):79∟.
doi: 10.1186/s40478-023-01569-y∟.
PMID: 37165457∟.
Review. ˍ
Sharma N, Mallela AN, Shi DD, Tang LW, Abou-Al-Shaar H, Gersey ZC,
Zhang X, McBrayer SK, Abdullah KG.
Isocitrate
dehydrogenase mutations in gliomas: A review of current
understanding and trials.
Neurooncol
Adv. 2023 May 10;5(1):vdad053∟.
doi: 10.1093/noajnl/vdad053∟.
PMID: 37287696∟.
Review. ˍ
Guo X, Sui R, Piao H.
Exosomes-mediated
crosstalk between glioma and immune cells in the tumor
microenvironment.
CNS
Neurosci Ther. 2023 May 11∟.
doi: 10.1111/cns.14239∟.
PMID: 37170647∟.
Review. ˍ
Li S, Dong L, Pan Z, Yang G.
Targeting
the neural stem cells in subventricular zone for the treatment of
glioblastoma: an update from preclinical evidence to clinical
interventions.
Stem
Cell Res Ther. 2023 May 11;14(1):125∟.
doi: 10.1186/s13287-023-03325-4∟.
PMID: 37170286∟.
Review. ˍ
Porter AB, Wen PY, Polley MC.
Molecular
Profiling in Neuro-Oncology: Where We Are, Where We're Heading,
and How We Ensure Everyone Can Come Along.
Am Soc Clin
Oncol Educ Book. 2023 May 11;43:e389322∟.
doi: 10.1200/EDBK_389322∟.
PMID: 37167580∟.
Review. ˍ
Erratum in: Am Soc Clin Oncol Educ Book. 2023 Jun
30;43:e389322CX1∟.
doi: 10.1200/EDBK_389322CX1∟.
PMID: 37390390∟.
Correction. ˍ
Srivastava R, Dodda M, Zou H, Li X, Hu B.
Tumor
niches: perspectives for targeted therapies in
glioblastoma.
Antioxid
Redox Signal. 2023 May 11∟.
doi: 10.1089/ars.2022.0187∟.
PMID: 37166370∟.
Review˰ ˍ
Alfonso-Triguero P, Lorenzo J, Candiota AP, Arús C,
Ruiz-Molina D, Novio F.
Platinum-Based
Nanoformulations for Glioblastoma Treatment: The Resurgence of
Platinum Drugs?
Nanomaterials
(Basel). 2023 May 12;13(10):1619∟.
doi: 10.3390/nano13101619∟.
PMID: 37242036∟.
Review. ˍ
Kumari S, Gupta R, Ambasta RK, Kumar P.
Multiple
therapeutic approaches of glioblastoma multiforme: From terminal
to therapy.
Biochim
Biophys Acta Rev Cancer. 2023 May 12:188913∟.
doi: 10.1016/j.bbcan.2023.188913∟.
PMID: 37182666∟.
Review˰ ˍ
Mofatteh M, Mashayekhi MS, Arfaie S, Chen Y, Malhotra AK, Alvi MA,
Sader N, Antonick V, Fatehi Hassanabad M, Mansouri A, Das S, Liao
X, McIntyre RS, Del Maestro R, Turecki G, Cohen-Gadol AA, Zadeh G,
Ashkan K.
Suicidal ideation and
attempts in brain tumor patients and survivors: A systematic
review.
Neurooncol Adv.
2023 May 12;5(1):vdad058∟.
doi: 10.1093/noajnl/vdad058∟.
PMID: 37313501∟.
Review. ˍ
Norris JN, Waack AL, Becker KN, Keener M, Hoyt A, Reinard
K.
Glioblastoma in pregnant patient
with pathologic and exogenous sex hormone exposure and family
history of high-grade glioma: A case report and review of the
literature.
Surg Neurol
Int. 2023 May 12;14:169∟.
doi: 10.25259/SNI_58_2023∟.
PMID: 37292394∟.
Case report, Review. ˍ
Starup-Hansen J, Williams SC, Funnell JP, Hanrahan JG, Islam S,
Al-Mohammad A, Hill CS.
Optimising
trajectory planning for stereotactic brain tumour biopsy using
artificial intelligence: a systematic review of the literature.
Br
J Neurosurg. 2023 May 13:1-10∟.
doi: 10.1080/02688697.2023.2210225∟.
PMID: 37177983∟.
Review˰ ˍ
Bonosi L, Marino S, Benigno UE, Musso S, Buscemi F, Giardina K,
Gerardi R, Brunasso L, Costanzo R, Iacopino DG, Maugeri
R.
Sonodynamic therapy and magnetic
resonance-guided focused ultrasound: new therapeutic strategy in
glioblastoma.
J
Neurooncol. 2023 May 14∟.
doi: 10.1007/s11060-023-04333-3∟.
PMID: 37179515∟.
Review. ˍ
Ceccarelli M.
Editorial: Cerebellar
development and medulloblastoma: new players and therapeutic
options.
Front Cell Dev
Biol. 2023 May 15;11:1214635∟.
doi: 10.3389/fcell.2023.1214635∟.
PMID: 37255598∟.
Review. ˍ
Eraky AM, Beck RT, Treffy RW, Aaronson DM, Hedayat H.
Role
of Advanced MR Imaging in Diagnosis of Neurological Malignancies:
Current Status and Future Perspective.
J
Integr Neurosci. 2023 May 15;22(3):73∟.
doi: 10.31083/j.jin2203073∟.
PMID: 37258452∟.
Review. ˍ
Yao B, Delaidelli A, Vogel H, Sorensen PH.
Pediatric
Brain Tumours: Lessons from the Immune Microenvironment.
Curr
Oncol. 2023 May 15;30(5):5024-5046∟.
doi: 10.3390/curroncol30050379∟.
PMID: 37232837∟.
Review. ˍ